Search

At AseBio, we believe this Executive Order creates uncertainty for the European biotechnology sector—especially for companies exporting to the U.S.—and we will continue working to help our member

The company received the recognition from the Ministry of Industry, presented by King Felipe VI, for its commitment to biotechnological innovation, industrial capacity and strengthening Europe’s

HIPRA Biotech Services reaches key milestones in its first year of operations, including signing its first agreement in just nine months and advancing new collaboration opportunities with European

The Kadans Tech Summit is an exclusive event bringing together European deep tech companies, technology leaders, academics and researchers.

Biobide, a subsidiary of Biotechnology Assets (BME Growth: BST), has obtained two Good Laboratory Practice (GLP) certifications granted by ENAC for chemicals, food additives and plant protection

Antonio Delgado participated in the panel “ From lab to fab: enabling scale up of bio-based innovations”

We consider a Biotech Act II that improves coordination, facilitates market access, and accelerates industrial development to be key in transforming European scientific potential into economic

BCN HEALTH has published the study “Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness” in ESC Heart Failure, a peer-reviewed journal of the European

The city of Salamanca reinforces its position as a strategic enclave for the bioeconomy and agri-food innovation in Castilla y León, hosting a meeting that aims to place the territory on the European

InceptionBio is a new €100 million target-size fund focused on biotech company creation and early-stage projects, with a strong focus on Spain.

Josep Samitier is a professor in the Department of Electronic and Biomedical Engineering at the University of Barcelona and leader of the Nanobioengineering group at IBEC and has been director of the

Covers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality Disorder (BPD).

Aptadel Therapeutics advances in its treatment for Ewing's sarcoma after closing a bridge round of 2 million euros.

According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants.

Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in combination with venetoclax and azacitidine.

Spain Prime Minister, Pedro Sánchez, recently visited the first maximum biosafety level (BSL-4) laboratory in Spain, located in Tres Cantos (Madrid). It is the world's only facility of its kind

Our Director General, Ion Arocena, participated in the latest meeting of the MEP Interest Group “EU Biotech and Life Sciences Alliance” with the aim of bringing clarity and guidance to the European